SolarEdge Technologies has just printed its sharpest weekly gain in months, up 22% to $48.76, on what appears to be an earnings-driven catalyst — yet short sellers have barely moved, leaving nearly 19% of the float still borrowed against the stock.
The short positioning tells the real story here. Short interest has barely budged on the week, edging up just 0.3% to 18.8% of the free float — roughly 11.3 million shares. That is an extraordinarily sticky short base for a stock that just rallied 22% in five sessions. Bears are not covering in any meaningful size, which speaks to persistent conviction on the short side rather than a panicked exit. The borrow market itself offers little ammunition for a squeeze: cost to borrow is just 0.55%, essentially free money to hold the position. What has shifted is borrow availability, which has tightened sharply — from around 75% a week ago to 47% now. That means the lending pool is narrowing, with roughly one share still available for every two already borrowed. It is well off the 52-week trough of 3.5%, so there is no imminent hard-to-borrow situation, but the direction is notable. Options traders are not adding to the drama: the put/call ratio at 0.59 sits right on its 20-day average, essentially flat, reflecting no unusual directional lean in either direction.
The Street is cautiously warming to the name, but analysts are not chasing the stock higher. Recent moves have been modest upgrades to targets rather than rating changes: Barclays raised its target to $53 from $41 while holding at Equal-Weight, and Susquehanna moved to $56 from $43 at Neutral — both firms marking up numbers but declining to turn bullish. TD Cowen trimmed its Buy target to $75 from $85 on July 20, leaving it as one of the few firms willing to hold a positive rating while the mean target has settled around $45. With the stock now at $48.76, it has actually traded through the Street consensus — a position that typically puts more pressure on bulls to upgrade targets or bears to explain why they have not. GLJ Research holds a Sell with a $6.90 target, a figure so far below current price levels that it reads more as a structural bear case than an actionable near-term call. The ORTEX factor scores add texture: EPS momentum over both 30 and 90 days ranks in the 89th and 95th percentiles respectively, and EPS surprise ranks in the 95th percentile. The short score and days-to-cover rank, however, both sit in the bottom 3rd percentile — a sign that the model flags meaningful short-side risk embedded in this name.
The institutional ownership picture has one standout detail. BlackRock added roughly 807,000 shares in the most recent reported quarter, taking its stake to 15.2% of shares outstanding. Harel Insurance, an Israeli firm, nearly doubled its disclosed position — adding 2.35 million shares to hold a 3.9% stake. That pattern of Israeli institutional interest in an Israeli-founded company is consistent, but the scale of Harel's addition is the kind of conviction buying that tends to provide a floor. Insider activity, while not recent, is worth context: the independent chairman bought 156,000 shares at $13.65 in November 2024 and added another 30,000 at $13.70 in March 2025. Those buyers are sitting on substantial gains at current prices, and the small sells recorded in May this year — totalling under $100,000 combined — look more like routine tax or compensation-related trims than a change in conviction.
Earnings just reported today, and the 22% weekly move is almost certainly the market's reaction to that result. The next scheduled print is November 4. Between now and then, the key variable to watch is whether the sticky short base begins to unwind — or whether the 19% float short, meeting tightening availability in the lending market, becomes a more live dynamic if the stock continues higher.
See the live data behind this article on ORTEX.
Open SEDG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.